Not Yet RecruitingNot Applicable

TECAR Therapy on Pain and Quality of Life in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Egypt60 participantsStarted 2026-01-02

Plain-language summary

Evaluate the effect of TECAR therapy on pain, voiding, erectile function, sleep quality and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome.

Who can participate

Age range30 Years – 50 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Urinary and seminal infections.
✕. Recent parenteral steroid administration.
✕. Prior prostate or pelvic surgery.
✕. Lower urinary tract disorders such as bladder stones.
✕. Implanted electronic devices as pacemakers.
✕. Sensory loss over the perineum.

What they're measuring

Pelvic pain

Timeframe: Baseline and 8 weeks later

Trial details

NCT IDNCT07324239

SponsorMiddle East University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-04-01

Contact for this trial

Saher Elgayar, Ph.D

+201020429911 saherlotfy020@gmail.com

View on ClinicalTrials.gov More Prostatitis trials